These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20017440)

  • 1. [High sensitivity cardiac troponin assays 2009: clinical potential, current practice and benefits, the future].
    Englis M; Sochman J; Pudil R; Franeková J; Jabor A
    Vnitr Lek; 2009 Nov; 55(11):1079-84. PubMed ID: 20017440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity.
    O'Brien PJ
    Toxicology; 2008 Mar; 245(3):206-18. PubMed ID: 18249481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and interpretation of cardiac troponins in the ED.
    Tsai SH; Chu SJ; Hsu CW; Cheng SM; Yang SP
    Am J Emerg Med; 2008 Mar; 26(3):331-41. PubMed ID: 18358946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing.
    Wu AH; Jaffe AS
    Am Heart J; 2008 Feb; 155(2):208-14. PubMed ID: 18215588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Troponin T, Troponin I and CK-MB (mass) in the detection of periprocedural myocardial damage after coronary angioplasty].
    La Vecchia L; Bedogni F; Finocchi G; Mezzena G; Martini M; Sartori M; Castellani A; Soffiati G; Vincenzi M
    Cardiologia; 1997 Apr; 42(4):405-13. PubMed ID: 9244645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Troponin T or troponin I or CK-MB (or none?).
    Collinson PO
    Eur Heart J; 1998 Nov; 19 Suppl N():N16-24. PubMed ID: 9857934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent cardiac troponin-I screening is an effective means of surveillance for a perioperative myocardial infarction.
    Martinez EA; Nass CM; Jermyn RM; Rosenbaum SH; Akhtar S; Chan DW; Malkus H; Weiss JL; Fleisher LA
    J Cardiothorac Vasc Anesth; 2005 Oct; 19(5):577-82. PubMed ID: 16202889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troponin as a biomarker of cardiac toxicity: past, present, and future.
    Reagan WJ
    Toxicol Pathol; 2010 Dec; 38(7):1134-7. PubMed ID: 20884820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of sensitive cardiac troponin assays: potential and limitations.
    Twerenbold R; Reichlin T; Mueller C
    Biomark Med; 2010 Jun; 4(3):395-401. PubMed ID: 20550473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troponins in acute coronary syndromes.
    Scirica BM; Morrow DA
    Semin Vasc Med; 2003 Nov; 3(4):363-74. PubMed ID: 15199443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Troponins: biological and clinical aspects].
    Lefèvre G
    Ann Biol Clin (Paris); 2000; 58(1):39-48. PubMed ID: 10673613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards appreciating appropriate clinical responses to highly sensitive cardiac troponin assays.
    Bima A; Sikaris K
    Intern Med J; 2012 Oct; 42 Suppl 5():16-22. PubMed ID: 23035677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A window into your heart: taking cardiac troponin to the next level.
    Hallén J; Atar D
    Biomark Med; 2010 Dec; 4(6):889-94. PubMed ID: 21133709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-sensitive troponin T measurements: what do we gain and what are the challenges?
    Twerenbold R; Jaffe A; Reichlin T; Reiter M; Mueller C
    Eur Heart J; 2012 Mar; 33(5):579-86. PubMed ID: 22267244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays.
    Jacobs LH; van de Kerkhof J; Mingels AM; Kleijnen VW; van der Sande FM; Wodzig WK; Kooman JP; van Dieijen-Visser MP
    Ann Clin Biochem; 2009 Jul; 46(Pt 4):283-90. PubMed ID: 19454537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will new higher-precision troponins lead to clarity or confusion?
    White HD
    Curr Opin Cardiol; 2008 Jul; 23(4):292-5. PubMed ID: 18520710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes.
    Newby LK; Roe MT; Chen AY; Ohman EM; Christenson RH; Pollack CV; Hoekstra JW; Peacock WF; Harrington RA; Jesse RL; Gibler WB; Peterson ED;
    J Am Coll Cardiol; 2006 Jan; 47(2):312-8. PubMed ID: 16412853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing specificity of high-sensitivity troponin: new approaches and perspectives in the diagnosis of acute coronary syndromes.
    Marini MG; Cardillo MT; Caroli A; Sonnino C; Biasucci LM
    J Cardiol; 2013 Oct; 62(4):205-9. PubMed ID: 23787156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration.
    Newby LK; Rodriguez I; Finkle J; Becker RC; Hicks KA; Hausner E; Chesler R; Harper C; Targum S; Berridge BR; Lewis E; Walker DB; Dollery C; Turner JR; Krucoff MW
    Am Heart J; 2011 Jul; 162(1):64-73. PubMed ID: 21742091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The new definition of myocardial infarction: analysis of the ESC/ACC Consensus Document and reflections on its applicability to the Italian Health System.
    Galvani M; Panteghini M; Ottani F; Cappelletti P; Chiarella F; Chiariello M; Crea F; Dolci A; Golino P; Greco C; Nicolosi GL; Plebani M; Tubaro M; Zaninotto M;
    Ital Heart J; 2002 Sep; 3(9):543-57. PubMed ID: 12407856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.